Outset Medical Stock Performance
| OM Stock | USD 5.01 0.06 1.18% |
The company holds a Beta of -0.95, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Outset Medical are expected to decrease slowly. On the other hand, during market turmoil, Outset Medical is expected to outperform it slightly. At this point, Outset Medical has a negative expected return of -1.1%. Please make sure to check Outset Medical's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Outset Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Outset Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (1.18) | Five Day Return (6.70) | Year To Date Return 35.41 | Ten Year Return (99.45) | All Time Return (99.45) |
Last Split Factor 1:15 | Last Split Date 2025-03-20 |
1 | Outset Medical Non-GAAP EPS of -0.69 misses by 0.03, revenue of 29.43M misses by 1.27M | 11/10/2025 |
2 | Disposition of 1548 shares by Drexler Karen of Outset Medical at 4.37 subject to Rule 16b-3 | 12/01/2025 |
3 | Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference | 01/05/2026 |
4 | Disposition of 1795 shares by Leslie Trigg of Outset Medical at 4.27 subject to Rule 16b-3 | 01/07/2026 |
5 | Insider Trading | 01/09/2026 |
6 | Outset Medical Reports Unaudited Fourth Quarter and 2025 Results | 01/12/2026 |
7 | Mantra Slashes Staff and Restructures Following Brutal OM Token Collapse | 01/14/2026 |
8 | Osisko recoupe 748 mtres une teneur moyenne de 0,27 percent cuivre Mines Gasp | 01/15/2026 |
9 | Disposition of 11794 shares by Leslie Trigg of Outset Medical at 5.12 subject to Rule 16b-3 | 01/20/2026 |
10 | Dont Ignore The Insider Selling In Outset Medical | 01/23/2026 |
11 | Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 | 01/26/2026 |
12 | OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System - Nasdaq | 01/28/2026 |
| Begin Period Cash Flow | 71.8 M | |
| Total Cashflows From Investing Activities | 103.9 M |
Outset Medical Relative Risk vs. Return Landscape
If you would invest 1,301 in Outset Medical on November 2, 2025 and sell it today you would lose (800.00) from holding Outset Medical or give up 61.49% of portfolio value over 90 days. Outset Medical is generating negative expected returns and assumes 8.6412% volatility on return distribution over the 90 days horizon. Put differently, 77% of stocks are less risky than Outset on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Outset Medical Target Price Odds to finish over Current Price
The tendency of Outset Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.01 | 90 days | 5.01 | about 63.09 |
Based on a normal probability distribution, the odds of Outset Medical to move above the current price in 90 days from now is about 63.09 (This Outset Medical probability density function shows the probability of Outset Stock to fall within a particular range of prices over 90 days) .
Allowing for the 90-day total investment horizon Outset Medical has a beta of -0.95. This indicates Additionally Outset Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Outset Medical Price Density |
| Price |
Predictive Modules for Outset Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Outset Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Outset Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Outset Medical is not an exception. The market had few large corrections towards the Outset Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Outset Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Outset Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.2 | |
β | Beta against Dow Jones | -0.95 | |
σ | Overall volatility | 3.59 | |
Ir | Information ratio | -0.15 |
Outset Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Outset Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Outset Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Outset Medical generated a negative expected return over the last 90 days | |
| Outset Medical has high historical volatility and very poor performance | |
| Outset Medical has a very high chance of going through financial distress in the upcoming years | |
| The company generated the yearly revenue of 113.69 M. Annual Net Loss to common stockholders was (127.98 M) with gross profit of 45.32 M. | |
| Outset Medical reports about 227.52 M in cash with (116.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System - Nasdaq |
Outset Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Outset Stock often depends not only on the future outlook of the current and potential Outset Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Outset Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.5 M | |
| Cash And Short Term Investments | 158.7 M |
Outset Medical Fundamentals Growth
Outset Stock prices reflect investors' perceptions of the future prospects and financial health of Outset Medical, and Outset Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Outset Stock performance.
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.73) % | ||||
| Operating Margin | (0.54) % | ||||
| Current Valuation | 15.1 M | ||||
| Shares Outstanding | 18.15 M | ||||
| Price To Book | 0.66 X | ||||
| Price To Sales | 0.77 X | ||||
| Revenue | 113.69 M | ||||
| Gross Profit | 45.32 M | ||||
| EBITDA | (97.89 M) | ||||
| Net Income | (127.98 M) | ||||
| Cash And Equivalents | 227.52 M | ||||
| Cash Per Share | 4.71 X | ||||
| Total Debt | 201.86 M | ||||
| Debt To Equity | 0.13 % | ||||
| Current Ratio | 6.24 X | ||||
| Book Value Per Share | 7.78 X | ||||
| Cash Flow From Operations | (116.3 M) | ||||
| Earnings Per Share | (11.56) X | ||||
| Market Capitalization | 92.04 M | ||||
| Total Asset | 275.8 M | ||||
| Retained Earnings | (1.09 B) | ||||
| Working Capital | 212.84 M | ||||
About Outset Medical Performance
By examining Outset Medical's fundamental ratios, stakeholders can obtain critical insights into Outset Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Outset Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 259.68 | 272.67 | |
| Return On Tangible Assets | (0.53) | (0.56) | |
| Return On Capital Employed | (0.44) | (0.46) | |
| Return On Assets | (0.53) | (0.56) | |
| Return On Equity | (5.49) | (5.21) |
Things to note about Outset Medical performance evaluation
Checking the ongoing alerts about Outset Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Outset Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Outset Medical generated a negative expected return over the last 90 days | |
| Outset Medical has high historical volatility and very poor performance | |
| Outset Medical has a very high chance of going through financial distress in the upcoming years | |
| The company generated the yearly revenue of 113.69 M. Annual Net Loss to common stockholders was (127.98 M) with gross profit of 45.32 M. | |
| Outset Medical reports about 227.52 M in cash with (116.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71. | |
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System - Nasdaq |
- Analyzing Outset Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Outset Medical's stock is overvalued or undervalued compared to its peers.
- Examining Outset Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Outset Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Outset Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Outset Medical's stock. These opinions can provide insight into Outset Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Will Health Care Equipment & Supplies sector continue expanding? Could Outset diversify its offerings? Factors like these will boost the valuation of Outset Medical. Anticipated expansion of Outset directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Outset Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (11.56) | Revenue Per Share | Quarterly Revenue Growth 0.027 | Return On Assets | Return On Equity |
Outset Medical's market price often diverges from its book value, the accounting figure shown on Outset's balance sheet. Smart investors calculate Outset Medical's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Outset Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Outset Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Outset Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.